These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27988386)

  • 1. New approaches to target glycinergic neurotransmission for the treatment of chronic pain.
    Imlach WL
    Pharmacol Res; 2017 Feb; 116():93-99. PubMed ID: 27988386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cord.
    Winters BL; Rawling T; Vandenberg RJ; Christie MJ; Bhola RF; Imlach WL
    Br J Pharmacol; 2018 Jun; 175(12):2337-2347. PubMed ID: 29500820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heteromeric α/β glycine receptors regulate excitability in parvalbumin-expressing dorsal horn neurons through phasic and tonic glycinergic inhibition.
    Gradwell MA; Boyle KA; Callister RJ; Hughes DI; Graham BA
    J Physiol; 2017 Dec; 595(23):7185-7202. PubMed ID: 28905384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Glycine Re-Uptake: A Potential Approach for Treating Pain by Augmenting Glycine-Mediated Spinal Neurotransmission and Blunting Central Nociceptive Signaling.
    Cioffi CL
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34200954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Glycine-Mediated Spinal Neurotransmission for the Treatment of Chronic Pain.
    Cioffi CL
    J Med Chem; 2018 Apr; 61(7):2652-2679. PubMed ID: 28876062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition Mediated by Glycinergic and GABAergic Receptors on Excitatory Neurons in Mouse Superficial Dorsal Horn Is Location-Specific but Modified by Inflammation.
    Takazawa T; Choudhury P; Tong CK; Conway CM; Scherrer G; Flood PD; Mukai J; MacDermott AB
    J Neurosci; 2017 Mar; 37(9):2336-2348. PubMed ID: 28130358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A System for Assessing Dual Action Modulators of Glycine Transporters and Glycine Receptors.
    Sheipouri D; Gallagher CI; Shimmon S; Rawling T; Vandenberg RJ
    Biomolecules; 2020 Nov; 10(12):. PubMed ID: 33266066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking glycine receptors reduces neuroinflammation and restores neurotransmission in cerebellum through ADAM17-TNFR1-NF-κβ pathway.
    Arenas YM; Cabrera-Pastor A; Juciute N; Mora-Navarro E; Felipo V
    J Neuroinflammation; 2020 Sep; 17(1):269. PubMed ID: 32917219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain.
    Dohi T; Morita K; Kitayama T; Motoyama N; Morioka N
    Pharmacol Ther; 2009 Jul; 123(1):54-79. PubMed ID: 19393690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic pain states: pharmacological strategies to restore diminished inhibitory spinal pain control.
    Zeilhofer HU; Benke D; Yevenes GE
    Annu Rev Pharmacol Toxicol; 2012; 52():111-33. PubMed ID: 21854227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PGE(2) selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons.
    Ahmadi S; Lippross S; Neuhuber WL; Zeilhofer HU
    Nat Neurosci; 2002 Jan; 5(1):34-40. PubMed ID: 11740501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination and inhibition of glycine receptor by HUWE1 in spinal cord dorsal horn.
    Zhang ZY; Guo Z; Li HL; He YT; Duan XL; Suo ZW; Yang X; Hu XD
    Neuropharmacology; 2019 Apr; 148():358-365. PubMed ID: 30721695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALX 1393 inhibits spontaneous network activity by inducing glycinergic tonic currents in the spinal ventral horn.
    Eckle VS; Antkowiak B
    Neuroscience; 2013 Dec; 253():165-71. PubMed ID: 23994185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycinergic dysfunction in a subpopulation of dorsal horn interneurons in a rat model of neuropathic pain.
    Imlach WL; Bhola RF; Mohammadi SA; Christie MJ
    Sci Rep; 2016 Nov; 6():37104. PubMed ID: 27841371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnenolone sulfate modulates glycinergic transmission in rat medullary dorsal horn neurons.
    Hong JS; Cho JH; Choi IS; Lee MG; Jang IS
    Eur J Pharmacol; 2013 Jul; 712(1-3):30-8. PubMed ID: 23665111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of spinal glycinergic neurons is not necessary for development of neuropathic pain in transgenic mice expressing enhanced green fluorescent protein in glycinergic neurons.
    Hermanns H; Muth-Selbach U; Lipfert P; Braun S; Werdehausen R; Bauer I
    Neuroscience; 2009 Mar; 159(3):1148-53. PubMed ID: 19356695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased C-fiber nociceptive input potentiates inhibitory glycinergic transmission in the spinal dorsal horn.
    Zhou HY; Zhang HM; Chen SR; Pan HL
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1000-10. PubMed ID: 18079355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycine transporter GlyT1, but not GlyT2, is expressed in rat dorsal root ganglion--Possible implications for neuropathic pain.
    Schlösser L; Barthel F; Brandenburger T; Neumann E; Bauer I; Eulenburg V; Werdehausen R; Hermanns H
    Neurosci Lett; 2015 Jul; 600():213-9. PubMed ID: 26101830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glycinergic control of spinal pain processing.
    Zeilhofer HU
    Cell Mol Life Sci; 2005 Sep; 62(18):2027-35. PubMed ID: 15968463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies.
    Zafra F; Ibáñez I; Giménez C
    Neuronal Signal; 2017 Feb; 1(1):NS20160009. PubMed ID: 32714574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.